🇺🇸 FDA
Patent

US 8106026

Development of a preventive vaccine for filovirus infection in primates

granted A61KA61K2039/5256A61K2039/53

Quick answer

US patent 8106026 (Development of a preventive vaccine for filovirus infection in primates) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/5256, A61K2039/53, A61K2039/545, A61K2039/55522